Wolf R M, Schneider S L, Pontes J E, Englander L, Karr J P, Murphy G P, Sandberg A A
Cancer. 1985 May 15;55(10):2477-81. doi: 10.1002/1097-0142(19850515)55:10<2477::aid-cncr2820551028>3.0.co;2-g.
Cytosol receptors for estrogens (ER) and progestins (PR) were assayed in human prostatic carcinoma (CaP) and benign prostatic hyperplasia (BPH). Specimens were obtained from either the peripheral or the periurethral zone of the prostate. Stringent criteria were used to identify and measure 7-8S specific receptor using sucrose gradient analysis in a vertical tube rotor. Progesterone receptor was found in 14 BPH samples assayed and in 12 of 13 prostate cancers. In contrast, the 7-8S estrogen receptor was found in none of the nine benign samples assayed and in all prostate cancers. BPH samples were taken from either peripheral or periurethral zones and gave similar results. The histology of individual specimens did not correlate with either the ER or PR present, and, in the cancers, there was no correlation between the pathologic stage or the Gleason score and receptor content.
对人前列腺癌(CaP)和良性前列腺增生(BPH)中的雌激素(ER)和孕激素(PR)胞质溶胶受体进行了检测。样本取自前列腺的外周区或尿道周围区。采用严格标准,使用垂直管转子中的蔗糖梯度分析法来鉴定和测量7 - 8S特异性受体。在所检测的14份BPH样本以及13例前列腺癌中的12例中发现了孕激素受体。相比之下,在所检测的9份良性样本中均未发现7 - 8S雌激素受体,而在所有前列腺癌中均有发现。BPH样本取自外周区或尿道周围区,结果相似。各个样本的组织学与所存在的ER或PR均无相关性,并且在癌症中,病理分期或Gleason评分与受体含量之间也无相关性。